MRI Quantitative T2* Mapping to Predict Dominant Composition of In Vitro Thrombus.
Journal
AJNR. American journal of neuroradiology
ISSN: 1936-959X
Titre abrégé: AJNR Am J Neuroradiol
Pays: United States
ID NLM: 8003708
Informations de publication
Date de publication:
01 2019
01 2019
Historique:
received:
08
08
2018
accepted:
21
10
2018
entrez:
13
1
2019
pubmed:
13
1
2019
medline:
2
1
2020
Statut:
ppublish
Résumé
MR imaging quantitative T2* mapping, which provides information about thrombus composition and specifically the red blood cell content, may be obtained in the setting of acute ischemic stroke before treatment. This could be useful to adapt the endovascular strategy. We aimed to analyze the red blood cell content of in vitro thrombi in relation to the thrombus-T2* relaxation time. Thirty-five thrombus analogs of different compositions were scanned with an MR imaging quantitative T2* mapping sequence. Two radiologists, blinded to thrombus composition, measured the thrombus-T2* relaxation time twice at an interval of 2 weeks. Quantitative histologic evaluations of red blood cell content were performed. Inter- and intraobserver reproducibility of the thrombus-T2* relaxation time was assessed by calculating intraclass correlation coefficients. Finally, a Spearman product moment correlation between the thrombus-T2* relaxation time and red blood cell content was performed. The median thrombus-T2* relaxation time was 78.5 ms (range, 16-268 ms; interquartile range, 60.5 ms). The median red blood cell content was 55% (range, 0%-100%; interquartile range, 75%). Inter- and intraobserver reproducibility of the thrombus-T2* relaxation time was excellent (>0.9). The Spearman rank correlation test found a significant inverse correlation between thrombus-T2* relaxation time and red blood cell content (ρ = -0.834, MR imaging quantitative T2* mapping can reliably identify the thrombus red blood cell content in vitro. This fast, easy-to-use sequence could be implemented in routine practice to predict stroke etiology and adapt devices or techniques for endovascular treatment of acute ischemic stroke.
Sections du résumé
BACKGROUND AND PURPOSE
MR imaging quantitative T2* mapping, which provides information about thrombus composition and specifically the red blood cell content, may be obtained in the setting of acute ischemic stroke before treatment. This could be useful to adapt the endovascular strategy. We aimed to analyze the red blood cell content of in vitro thrombi in relation to the thrombus-T2* relaxation time.
MATERIALS AND METHODS
Thirty-five thrombus analogs of different compositions were scanned with an MR imaging quantitative T2* mapping sequence. Two radiologists, blinded to thrombus composition, measured the thrombus-T2* relaxation time twice at an interval of 2 weeks. Quantitative histologic evaluations of red blood cell content were performed. Inter- and intraobserver reproducibility of the thrombus-T2* relaxation time was assessed by calculating intraclass correlation coefficients. Finally, a Spearman product moment correlation between the thrombus-T2* relaxation time and red blood cell content was performed.
RESULTS
The median thrombus-T2* relaxation time was 78.5 ms (range, 16-268 ms; interquartile range, 60.5 ms). The median red blood cell content was 55% (range, 0%-100%; interquartile range, 75%). Inter- and intraobserver reproducibility of the thrombus-T2* relaxation time was excellent (>0.9). The Spearman rank correlation test found a significant inverse correlation between thrombus-T2* relaxation time and red blood cell content (ρ = -0.834,
CONCLUSIONS
MR imaging quantitative T2* mapping can reliably identify the thrombus red blood cell content in vitro. This fast, easy-to-use sequence could be implemented in routine practice to predict stroke etiology and adapt devices or techniques for endovascular treatment of acute ischemic stroke.
Identifiants
pubmed: 30635330
pii: 40/1/59
doi: 10.3174/ajnr.A5938
pmc: PMC7048613
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
59-64Informations de copyright
© 2019 by American Journal of Neuroradiology.
Références
N Engl J Med. 2015 Jun 11;372(24):2285-95
pubmed: 25882376
J Neurointerv Surg. 2017 Jun;9(6):529-534
pubmed: 27166383
Lancet. 2004 Jan 31;363(9406):357-62
pubmed: 15070565
Stroke. 2006 Aug;37(8):2086-93
pubmed: 16794209
Stroke. 2016 Jul;47(7):1864-71
pubmed: 27197854
N Engl J Med. 2015 Jan 1;372(1):11-20
pubmed: 25517348
PLoS One. 2013 Oct 11;8(10):e76727
pubmed: 24146915
J Neuroradiol. 2012 May;39(2):71-86
pubmed: 22342939
N Engl J Med. 2015 Jun 11;372(24):2296-306
pubmed: 25882510
J Neurointerv Surg. 2017 Mar;9(3):257-263
pubmed: 27016318
Lancet. 2016 Apr 23;387(10029):1723-31
pubmed: 26898852
J Chiropr Med. 2016 Jun;15(2):155-63
pubmed: 27330520
Stroke. 2016 Dec;47(12):3035-3037
pubmed: 27780903
N Engl J Med. 2015 Mar 12;372(11):1019-30
pubmed: 25671798
J Neuroradiol. 2017 Jul;44(4):241-246
pubmed: 28478114
Cerebrovasc Dis Extra. 2013 Sep 24;3(1):111-20
pubmed: 24163686
N Engl J Med. 2015 Mar 12;372(11):1009-18
pubmed: 25671797
Radiology. 2016 Jun;279(3):720-30
pubmed: 26653680
J Neurointerv Surg. 2018 Sep;10(9):907-910
pubmed: 29352061
Clin Neuroradiol. 2016 Jun;26(2):189-97
pubmed: 25261075
Stroke. 2016 Mar;47(3):732-41
pubmed: 26846859
Stroke. 2011 May;42(5):1237-43
pubmed: 21393591
Neuroradiology. 2015 Sep;57(9):909-15
pubmed: 26070299
Eur J Neurol. 2015 Jun;22(6):967-72
pubmed: 25786977
Yonago Acta Med. 2016 Sep 12;59(3):204-209
pubmed: 27708535
Radiology. 2004 Aug;232(2):466-73
pubmed: 15215546
Eur Neurol. 2011;65(5):291-5
pubmed: 21508643
J Neurointerv Surg. 2017 May;9(5):486-491
pubmed: 27127231
J Neuroimaging. 2017 Nov;27(6):577-582
pubmed: 28771893